Prosecution Insights
Last updated: October 04, 2026

Cas Center For Excellence In Molecular Plant Sciences

Technology area: Biotechnology & Pharmaceuticals

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Cas Center For Excellence In Molecular Plant Sciences operates within the Biotechnology & Pharmaceuticals technology area, currently managing 4 pending office actions. These actions are distributed across 4 distinct examiners, showing that each examiner is responsible for a single matter. This distribution suggests that no single examiner holds the bulk of the company's active workload, as even the busiest examiner, SHEN, YANXIN NMN, is only responsible for 1 pending office action.

The portfolio's activity spans 2 distinct art units, which indicates technical diversity within its specialized field. Because the 4 pending office actions are spread across 4 distinct examiners, the company must navigate multiple individual examination styles simultaneously. The presence of 2 distinct art units further suggests that while the focus remains on Biotechnology & Pharmaceuticals, the specific technical challenges vary across the active matters.

With SHEN, YANXIN NMN handling 1 pending office action, the workload is split among the 4 distinct examiners. This lack of concentration means that the overall prosecution strategy is not reliant on the tendencies of a single individual. Instead, the 4 pending office actions represent a decentralized set of interactions across the 2 distinct art units involved.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (50%)
1
Medium (25%)
0
Easy (0%)
1
Unknown (25%)

Rejection Statute Mix

BucketCases
§103 only1 (25%)
Multi-statute (no §101)2 (50%)
No statute on record1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHEN, YANXIN NMN 1 90.0% +22.5%
MEADOWS, CHRISTINA L 1 76.1% +23.2%
RADOSAVLJEVIC, ALEKSANDAR 1 81.7% +8.7%
BYRNES, DAVID R 1 78.1% +22.2%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17786645 Application of EMBP1 Gene or Protein Thereof RADOSAVLJEVIC, ALEKSANDAR 16d overdue
18288069 Application of Phosphorus Starvation Response Factor PHR2 in Plant and Arbuscular Mycorrhizal Symbiosis and Improving Phosphorus Nutrition SHEN, YANXIN NMN 34d

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18001541 Use of SHR-SCR in Leguminous Cortical Cell Fate Determination and Non-leguminous Cortical Cell Division Potential Modification MEADOWS, CHRISTINA L 9d overdue
17050168 REPEAT-MEDIATED PLANT SITE-SPECIFIC RECOMBINATION METHOD BYRNES, DAVID R 1d overdue
18288069 Application of Phosphorus Starvation Response Factor PHR2 in Plant and Arbuscular Mycorrhizal Symbiosis and Improving Phosphorus Nutrition SHEN, YANXIN NMN 34d

Top Art Units

Art UnitApps
1663 2
1662 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18288069 Application of Phosphorus Starvation Response Factor PHR2 in Plant and Arbuscular Mycorrhizal Symbiosis and Improving Phosphorus Nutrition SHEN, YANXIN NMN 1663 §102§103§112 Non-Final OA 34d Pending Oct 24, 2023
18001541 Use of SHR-SCR in Leguminous Cortical Cell Fate Determination and Non-leguminous Cortical Cell Division Potential Modification MEADOWS, CHRISTINA L 1663 §103 Final Rejection 9d overdue Pending Jul 11, 2023
17786645 Application of EMBP1 Gene or Protein Thereof RADOSAVLJEVIC, ALEKSANDAR 1662 §103§112 Non-Final OA 16d overdue Pending Jun 17, 2022
17050168 REPEAT-MEDIATED PLANT SITE-SPECIFIC RECOMBINATION METHOD BYRNES, DAVID R 1662 — Final Rejection 1d overdue Pending Oct 23, 2020

Managing Cas Center For Excellence In Molecular Plant Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month